• Eldecalcitol Reduces Endothelial Ferroptosis in Diabetic Ost

  2026-06-17

  This study demonstrates that eldecalcitol mitigates type 2 diabetic osteoporosis by suppressing endothelial cell ferroptosis via the SOCE/O-GlcNAcylation signaling axis. The research provides mechanistic insight into vascular-bone coupling and highlights advanced approaches for lipid peroxidation detection in disease models.

• TTP Modulates m6A Methylation to Attenuate Schistosomiasis F

  2026-06-17

  This study uncovers a novel mechanism by which tristetraprolin (TTP) ameliorates schistosomiasis-induced liver fibrosis through the epitranscriptomic regulation of TGF-β1 mRNA stability via m6A methylation. The findings highlight a potential therapeutic strategy targeting TTP-mediated RNA methylation pathways to inhibit hepatic stellate cell activation and fibrotic progression.

• TBK1 Inhibition Reduces Painful Diabetic Neuropathy via Micr

  2026-06-16

  Liao et al. identify TANK-binding kinase 1 (TBK1) as a pivotal driver of painful diabetic neuropathy (PDN) through its regulation of microglial pyroptosis. Their study demonstrates that targeting TBK1, using siRNA or amlexanox, attenuates PDN in mouse models, highlighting a novel therapeutic avenue for diabetes-associated neuroinflammation.

• HDAC Inhibition in Neuroblastoma: M344 Outperforms Vorinosta

  2026-06-16

  Brumfield et al. (2025) demonstrate that the HDAC inhibitor M344 suppresses neuroblastoma tumor growth more effectively than vorinostat in preclinical models. Their study uncovers critical mechanisms, including enhanced histone acetylation, cell cycle arrest, and apoptotic induction, supporting the advancement of HDAC-targeted therapies in pediatric oncology.

• LINC01278-Induced Autophagy Suppresses Uveal Melanoma via mT

  2026-06-15

  This study uncovers the tumor-suppressive role of lncRNA LINC01278 in uveal melanoma, showing it induces autophagy by inhibiting mTOR signaling. The findings highlight LINC01278 as a potential prognostic biomarker and therapeutic target, and validate mTOR inhibition as a mechanistic axis in tumor suppression.

• Dacomitinib (PF-00299804): Unraveling Mitochondrial Links in

  2026-06-15

  Discover how Dacomitinib (PF-00299804) enables advanced interrogation of mitochondrial signaling and cell death pathways in cancer research. Explore unique perspectives on apoptosis, cell cycle arrest, and the interplay with ferroptosis, setting this article apart from existing guides.

• Berberrubine Chloride: Applied Workflows for Translational C

  2026-06-14

  Berberrubine chloride, a multi-target alkaloid, empowers researchers with reproducible pathway inhibition and advanced workflow flexibility in cancer and metabolic disease models. This guide translates the latest mechanistic and protocol innovations into actionable steps, troubleshooting, and comparative insights for maximizing data quality in preclinical experiments.

• 3-Deazaneplanocin (DZNep): Precision Epigenetic Modulation i

  2026-06-13

  Explore how 3-Deazaneplanocin (DZNep) redefines epigenetic modulation for advanced oncology research. This article provides a unique, evidence-based guide to optimizing DZNep protocols and interpreting its mechanistic impact on cancer cell fate.

• BODIPY 581/591 C11: Ratiometric Lipid Peroxidation Detection

  2026-06-12

  This article guides biomedical researchers through real-world challenges in oxidative stress measurement, demonstrating how BODIPY 581/591 C11 (SKU C8003) offers reproducible, ratiometric detection of lipid peroxidation. Evidence-backed workflow tips and vendor selection advice are integrated to support robust cell viability and antioxidant capacity evaluation.

• Fluorescein TSA Fluorescence System Kit: Amplifying Low-Abun

  2026-06-12

  The Fluorescein TSA Fluorescence System Kit delivers unparalleled sensitivity for detecting low-abundance proteins and nucleic acids, transforming immunohistochemistry, immunocytochemistry, and in situ hybridization workflows. Discover how this kit empowers researchers with robust signal amplification, actionable troubleshooting, and cross-domain assay innovation.

• Cy3-UTP: Transforming RNA Interaction Studies and Imaging

  2026-06-11

  Explore how Cy3-UTP catalyzes new discovery in RNA biology by enabling detailed visualization and mechanistic interrogation of RNA-protein and RNA-RNA interactions, with translational implications for nucleolar architecture and disease modeling.

• Direct Mouse Genotyping Kit Plus: Rapid, High-Fidelity Genot

  2026-06-11

  The Direct Mouse Genotyping Kit Plus enables rapid, direct PCR from mouse tissue lysates, eliminating DNA purification steps. This workflow accelerates mouse genotyping assays and improves reproducibility, making it ideal for transgene detection and gene knockout validation.

• 3-Deazaadenosine: Dissecting Epigenetic and Antiviral Pathwa

  2026-06-10

  Explore how 3-Deazaadenosine, a leading S-adenosylhomocysteine hydrolase inhibitor, enables advanced research into methylation-dependent regulation and antiviral defense. This article reveals unique mechanistic insights and practical assay guidance.

• D-N-Acetylgalactosamine: Technical Protocols and QC for Brai

  2026-06-10

  D-N-Acetylgalactosamine is a high-purity, water-soluble standard essential for the precise analysis of glycoprotein constituents and glycosylation pathways in neurological research. It is not appropriate for workflows requiring ethanol solubility or long-term storage of working solutions. Correct handling and storage are critical to ensure reproducibility and data integrity.

• Amikacin Sulfate: Targeted Delivery for Mycobacterial Resear

  2026-06-09

  Harness the full translational impact of Amikacin Sulfate for advanced, targeted treatment of non-tuberculous mycobacterial infections. This article delivers stepwise protocols, troubleshooting insights, and actionable guidance to maximize intracellular and granuloma-focused efficacy using APExBIO’s trusted compound.

15902 records 1/1061 page Next 12345 下5页 Last page